| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Shire Presents Data on Venvanse | | 2 | Zacks |
| 24.05.
| Downtrend Call Working As Shire Stock Falls 14.2% | | 1 | SmarTrend |
| 23.05.
| SHIRE PLC - Block listing six monthly return | | 20 | PR Newswire |
| Block listing six monthly return
May 23, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPGY)
Name of applicant: Shire plc
...
Mehr lesen zu:
SHIRE PLC - Block listing six monthly return | |
| 23.05.
| Shire plc - 10-Q/A, Quarterly Report | | 1 | SEC Filings |
| 22.05.
| Possible Bullish Inside Day Candle Pattern Detected for Shire | | 3 | SmarTrend |
| 18.05.
| The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft | | 71 | PR Newswire |
| CHICAGO, May 18, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft | |
| 18.05.
| Deutsche Bank belässt Shire auf 'Buy' - Ziel 2.250 Pence | | 88 | APA-dpa-AFX-Analyser |
| Die Deutsche Bank hat die Einstufung
für Shire auf "Buy" mit einem Kursziel von 2.250 Pence belassen.
Generika stellten zwar ein gewisses Risiko dar, doch insgesamt
erachte er die Position des...
Mehr lesen zu:
Deutsche Bank belässt Shire auf 'Buy' - Ziel 2.250 Pence | |
| 17.05.
| Watson and Shire in Legal Battle | | 4 | Zacks |
| 16.05.
| Why Shire May Be About to Take Off | | 8 | Motley Fool |
| 14.05.
| Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th | | 47 | PR Newswire |
| LEXINGTON, Mass., May 14, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its support of the first global hereditary angioedema...
Mehr lesen zu:
Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th | |
| 14.05.
| Shire Earnings Review: 18 Days after Announcement Shares Down 0.3% | | - | SmarTrend |
| 10.05.
| Watson confirms ANDA filing to market Shire Lialda | | 2 | Pharma Bus Review |
| 06.05.
| Ravensthorpe Shire welcomes First Quantum's nickel mine results | | 1 | SteelGuru |
| 04.05.
| Shire To Present Scientific Data Across Range Of Psychiatric Disorders | | 71 | AFX News |
| SAINT HELIER (dpa-AFX) - Shire plc (SHPGY, SHP.L) announced that it will
present scientific data from one oral and 16 poster presentations at the
American Psychiatric Association 165th Annual...
Mehr lesen zu:
Shire To Present Scientific Data Across Range Of Psychiatric Disorders | |
| 04.05.
| Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9 | | 23 | PR Newswire |
| PHILADELPHIA, May 4, 2012 /PRNewswire/ --
Research Explores Treatments for ADHD and Investigates Other Psychiatric Disorders; Health Economics and Outcomes Data Also to Be Presented
Shire plc (LSE:...
Mehr lesen zu:
Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9 | |
| 01.05.
| SHIRE PLC - Total Voting Rights | | 27 | PR Newswire |
| Total Voting Rights
May 1, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, in accordance with DTR 5.6.1 of the FSA's Disclosure
and Transparency Rules...
Mehr lesen zu:
SHIRE PLC - Total Voting Rights | |
| 29.04.
| Shire's stumble could help Protalix on Gaucher's treatment | | 6 | Globes |
| 26.04.
| UPDATE 2-ADHD drugs boost Shire's Q1 earnings | | 2 | Reuters.com |
| 26.04.
| Shire Q1 Profit Up; Backs Forecast | | 48 | AFX News |
| SAINT HELIER (dpa-AFX) - Shire plc (SHP.L, SHPGY) said first quarter net
income rose to $238.4 million or 41.4 cents per share from $211.3 million or
37.0 cents per share last year.Earnings...
Mehr lesen zu:
Shire Q1 Profit Up; Backs Forecast | |
| 26.04.
| Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth | | 31 | PR Newswire |
| DUBLIN, April 26, 2012 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces results for the three months to March 31, 2012.
Financial...
Mehr lesen zu:
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth | |
